
Collaborating with colleagues at Princess Margaret Cancer Centre in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) in Phoenix have discovered why multiple myeloma frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years.
“Some myeloma cells are too immature to be caught by the drugs and thus hide underground only to reemerge later,” says Keith Stewart, M.B., Ch.B., Dean for Research at Mayo Clinic in Arizona and contributor to the study. “This study has wide implications in the search for a cure of this common blood cancer as this ‘progenitor cell’ will have to be targeted.”
The study is published in the Sept. 9 issue of Cancer Cell.
Click here to read the full news release.
Colorectal cancer is a cancer of the lower digestive system, which includes the colon and the rectum. If you feel like you are hearing a ...
Stacy Weisensel and her husband Joshua had a goal: to take their daughters to as many national parks as possible. But in the summer of ...
As a physician at the forefront of new cancer therapies, Yi Lin, M.D., Ph.D., understands the highs and lows that patients experience. Will the latest technologies ...